Skip to Main Content
Yale Only

Radiobiology and Genome Integrity Research Program - “The Use of CRISPR-Cas9 Technology to Uncover Novel Therapeutic Targets to Enhance Meningioma Radiosensitivity”

Jan 202231Monday